|
SERTAD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.20390000002413E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.75530999999562E-05 |
| Normal-vs-Stage2 |
5.733600E-01 |
| Normal-vs-Stage3 |
1.770360E-04 |
| Normal-vs-Stage4 |
1.61633999999911E-05 |
| Stage1-vs-Stage2 |
1.135410E-01 |
| Stage1-vs-Stage3 |
8.006800E-01 |
| Stage1-vs-Stage4 |
1.831020E-01 |
| Stage2-vs-Stage3 |
1.020820E-01 |
| Stage2-vs-Stage4 |
2.682100E-02 |
| Stage3-vs-Stage4 |
3.766400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.63000000000346E-07 |
| Normal-vs-AfricanAmerican |
2.181900E-03 |
| Normal-vs-Asian |
1.904320E-03 |
| Caucasian-vs-AfricanAmerican |
6.381700E-02 |
| Caucasian-vs-Asian |
6.384200E-01 |
| AfricanAmerican-vs-Asian |
1.086590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.731890E-02 |
| Normal-vs-Female |
2.12999999971153E-07 |
| Male-vs-Female |
2.471500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.15399999999866E-05 |
| Normal-vs-Age(41-60Yrs) |
4.25969999999776E-05 |
| Normal-vs-Age(61-80Yrs) |
9.242300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.776760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.187600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.568400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.396800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.669000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.149200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.038400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.171400E-01 |
| Classical-VS-Follicular |
5.6621374255883E-15 |
| Classical-VS-Other |
2.107600E-02 |
| Classical-VS-Normal |
4.46860326519527E-11 |
| Tall-VS-Follicular |
3.3173999991476E-08 |
| Tall-VS-Other |
8.923800E-03 |
| Tall-VS-Normal |
2.5365000000388E-06 |
| Follicular-VS-Other |
7.455600E-01 |
| Follicular-VS-Normal |
3.264300E-02 |
| Other-VS-Normal |
6.770200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.301800E-02 |
| Normal-vs-N1 |
8.238600E-03 |
| N0-vs-N1 |
2.036800E-01 |
|
|
